Curriculum vitae
1. Personal Data
Place of Birth: Winston-Salem, NC, USA
2. Education
May 2005: B.A., Anthropology, Wake Forest University, Winston-Salem, NC
Aug 2010: M.P.H., Health Care and Prevention, University of North Carolina, Chapel Hill, NC
May 2011: M.D., University of North Carolina, Chapel Hill, NC
Sept 2015-Dec 2016: Graduate Non-Matriculated student in Epidemiology, University of Washington, Seattle, WA
Oct 2021-Nov 2021: Leadership Development for Physicians in Academic Settings Certificate Program, Harvard T.H. Chan School of Public Health, Boston, MA
3. Postgraduate Training
2011- 2012: Intern, Internal Medicine, University of California, San Francisco, San Francisco, CA
2012 -2014: Resident, Internal Medicine, University of California, San Francisco, San Francisco, CA
2014 - 2017: Fellow, Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA
4. Faculty positions held
2017- Assistant Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center
2017- Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine; Department of Medicine, University of Washington
5. Hospital positions held
2017- Attending Physician, Seattle Cancer Care Alliance and University of Washington
6. Honors
2001-2005 Wake Forest Honors Scholarship
2003-2005 Mullen Upperclass Carswell Scholarship
2004 Rotary Ambassadorial Fellowship Award
2005 Outstanding Anthropology Senior Award, Wake Forest University
2005 Summa Cum Laude, Wake Forest University
2005 Phi Beta Kappa Honors Society
2010 Delta Omega Honors Society (AOA equivalent for public health)
2010 Alpha Omega Alpha (AOA) Honors Society
2010 MD with distinction (highest honors), University of North Carolina
2017 Young Investigator Scholarship Recipient, CROI
2017 Abstract Scholarship, Assembly on Clinical Problems, ATS
2019 Entering 2017 Medical Student Class Outstanding Research Mentor Award
2020 Early Career Achievement Award, Thoracic Oncology Assembly, ATS
2021 High Potentials Program Leadership Award, Seattle Cancer Care Alliance
2021 Outstanding Research Mentor Award, UW School of Medicine
7. Board Certifications
2014 American Board of Internal Medicine
2017 ABIM Pulmonary Medicine
2018 ABIM Critical Care
8. License to Practice
2013-2014 California, License number 124242
2014- Washington, License number MD60454739
9. Professional Organizations
2013- American College of Physicians
2016- American Thoracic Society
10. Teaching Responsibilities
2007-2009 Co-Coordinator and Preceptor, Student Health Action Coalition (SHAC) HIV testing services
2009-2011 Teaching Assistant, Introduction to Clinical Medicine, University of North Carolina School of Medicine
2012-2014 Health Professions Education Pathway, University of California, San Francisco
2013-2014 Preceptor, University of California San Francisco Homeless Clinic
2015 Course instructor, small group leader. Human Biology 541: Respiratory System.
2016-2021 Course instructor, annual Internal Medicine procedure workshop, UW
2018 Course instructor, annual Pulmonary fellow “mini-sabbatical” EBUS workshop, UW. February 1, 2018.
2018- Lecturer, “Lung cancer and obstructive lung diseases”, Pulmonary 610 (4th year medical student elective)
2019 Course instructor, small group leader. MedSci 530A Circulatory Systems.
11. Editorial Responsibilities
Ad Hoc Reviewer
New England Journal of Medicine (2020-present) (1)
Journal of Acquired Immune Deficiency Syndromes (2016-present) (2)
AIDS (2017-present) (1)
PLoS ONE (2017-present) (1)
Annals of ATS (2017-present) (8)
European Respiratory Journal (2018-present) (1)
Chest (2018-present) (3)
American Journal of Respiratory and Critical Care Medicine (2019-present) (3)
12. Special National Responsibilities
2019-2021 Early Career Working Group Member. Thoracic Oncology Assembly, American Thoracic Society.
2021-2022 Chair-elect, Early Career Working Group. Thoracic Oncology Assembly, American Thoracic Society.
2021- Member, Program Committee. Thoracic Oncology Assembly, American Thoracic Society.
2021-2022 Member, National Comprehensive Cancer Network Smoking Cessation Guideline Panel
13. Special Local Responsibilities
2017-2018 Member, Lung Cancer Screening Expansion Workgroup (UW)
2018- Member/Director (2020-), Lung Cancer Screening Oversight Committee (UW/SCCA)
2018 Chair, Planning Committee, American Lung Association (ALA) Lung Force Day (Lung cancer screening educational symposium) (March 21, 2018)
2018- Board member, Local Leadership Board for American Lung Association, Washington
2019 Member, faculty search committee for Pulmonary, Critical Care and Sleep Medicine. Clinical Research Division, Fred Hutchinson Cancer Research Center (Hire: Viswan Nair)
2019 Chair, Planning Committee, American Lung Association (ALA) Lung Force Expo (May 10, 2019)
2019- Medical Director, həliʔil Program (Snoqualmie-SCCA Tobacco Cessation and Prevention Partnership)
2019-2020 Member, Fellowship Curriculum Working Group, Division of Pulmonary, Critical Care and Sleep Medicine (UW)
2019- Member, Pulmonary Research Seminar Planning Committee, Division of Pulmonary, Critical Care and Sleep Medicine (UW)
2020- Medical Director, Lung Cancer Screening Program, UW/SCCA
2020- Medical Director, Lung Cancer Early Detection and Prevention Clinic, SCCA
2020- Medical Director, Living Free Tobacco Services, SCCA
2021- Member, Fellowship Selection Committee, Division of Pulmonary, Critical Care and Sleep Medicine (UW)
2021 Member, faculty search committee for Pulmonary, Critical Care and Sleep Medicine. Clinical Research Division, Fred Hutchinson Cancer Research Center
14. Research Support
A. Current
Sponsor: LUNGevity Foundation
Health Equity for Communities Research Award
Title: Tailoring screening and smoking cessation for the LGBTQ community
Role: PI
12/1/21-11/30/23
Sponsor: NIH/NCI
R01CA262015-01
Title: Multilevel interventions to increase adherence to lung cancer screening
Role: Co-I/Site PI (Wernli)
07/15/21-06/30/26
Sponsor: NIH/NCI
Aging in HIV P30 CCSG Supplement
Title: “Tailoring shared decision making for lung cancer screening in persons living with HIV”
Role: Co-Project Leader (with Crothers)
09/01/20-08/31/22
Sponsor: NIH/NCI
Cancer Moonshot Cancer Center Cessation Initiative (C3I) P30 CCSG Supplement
Title: “Hit Refresh: Upgrading Living Tobacco Free Services at an NCI Designated Cancer Center”
Role: Project Leader
09/01/20-08/31/21
Sponsor: American Lung Association
Lung Cancer Discovery Award
Title: Improving Implementation of Lung Cancer Screening in Diverse Populations
Role: Co-I/Site PI (PI Crothers)
08/2018-12/31/21
15. Bibliography
a) Manuscripts in referred journals
1. Triplette MA, Rossi JS, Viera AJ, Cohen MG, Pathman DE. The contribution of hypertension to black-white differences in likelihood of coronary artery disease detected during elective angiography. American Journal of Hypertension. 2011 Feb; 24(2): 181-6. [original work]
2. Feldacker C, Torrone E, Triplette M, Smith JC, Leone PA. Reaching and retaining high-risk HIV/AIDS clients through the internet. Health Promotion Practice. 2011 Jul; 12(4): 522-8. [original work]
3. Clausen JA, Blish KR, Sirse CE, Triplette MA, Kute TE, Russell GB, D’Agostino RB Jr, Miller LD, Torti FM, Torti SV. SOSTDC1 differentially modulates Smad and beta-catenin activation and is down-regulated in breast cancer. Breast Cancer Research and Treatment. 2011 Oct; 129(3): 737-46. [original work]
4. Federspiel JJ, Stearns SC, Reiter KL, Geissler KH, Triplette MA, D’Arcy LP, Sheridan BC, Rossi JS. Disappearing and reappearing differences in drug-eluting stent use by race. Journal of Evaluation in Clinical Practice. 2013 Apr; 19(2): 256-62. [original work]
5. Stalls CM, Triplette MA, Viera AJ, Pathman DE, Cohen MG, Rossi JS. The association between body mass index and coronary artery disease severity: a comparison of black and white patients. American Heart Journal. 2014 Apr; 167(4):514-20. [original work]
6. Triplette M, Crothers K, Attia EF. Non-infectious pulmonary diseases and HIV. Current HIV/AIDS Reports. 2016 June; 13(3): 140-8. [review]
7. Crothers K, Kross E, Reisch L, Shahrir S, Slatore C, Zeliadt S, Triplette M, Meza R, Elmore J. Patients’ attitudes regarding lung cancer screening and decision aids: A survey and focus group study. Annals of the ATS. 2016 Nov;13(11):1992-2001. [original work]
8. Triplette M, Attia E, Akgun K, Campo M, Rodriguez-Barradas M, Pipavath S, Shahrir S, Wongtrakool C, Goetz M, Kim J, Soo Hoo G, Brown S, Crothers K. The differential impact of emphysema on respiratory symptoms and six-minute walk distance in HIV infection. JAIDS. 2017 Jan 1; 74(1): e23-29. [original work]
9. Triplette M, Attia E, Akgun K, Soo Hoo G, Freiberg M, Butt A, Wongtrakool C, Goetz M, Brown S, Graber C, Huang L, Crothers K. A low peripheral blood CD4/CD8 ratio is associated with pulmonary emphysema in HIV. PLoS ONE. 2017 Jan 25;12(1). [original work]
10. Triplette M, Sigel KM, Morris AM, Shahrir S, Wisnivesky JP, Kong CY, Diaz PT, Crothers K. Emphysema and soluble cD14 are associated with incidental non-calcified pulmonary nodules in HIV-infected patients: Implications for lung cancer screening. AIDS. 2017. Jul 13l 31(12): 1715-1720. [original work]
*11. Triplette M, Kross EK, Mann B, Elmore JG, Slatore CG, Shahrir S, Frederick PD, Romine PE, Crothers K. An assessment of primary care and pulmonary provider perspectives on lung cancer screening. Annals of the ATS. 2018 Jan; 15(1): 69-75. [original work]
*12. Triplette M, Brown ST, Goetz MB, Kim JW, Rodriguez-Barradas M, Soo Hoo GW, Wongtrakool C, Akgun K, Justice A, Crothers K. Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV. AIDS. 2018 Feb 20; 32(4): 487-493. [original work]
13. Kong CY, Sigel K, Sheehan DF, Triplette M, Silverberg MJ, Criss SD, Henschike CI, Justice A, Braithwaite RS, Wisnivesky J, Crothers K. Benefits and harms of lung cancer screening in HIV-infected individuals: A simulation study. AIDS. 2018 June 19; 32(10): 1333-1342. [original work]
*14. Triplette M, Crothers K, Yanik EL, Valapour M, Lynch CF, Schabath M, Engels EA. Risk of lung cancer in lung transplant recipients in the United States. American Journal of Transplantation. 2018 Dec 18. Epub ahead of print. [original work]
15. Triplette M, Thayer JH, Pipavath S, Crothers, K. Poor uptake of lung cancer screening: Opportunities for improvement. Journal of the American College of Radiology. 2019 Apr; 16: 446-450. [review]
*16. Triplette M, Donovan LM, Crothers K, Madtes DK, Au DH. Prediction of lung cancer screening eligibility using simplified criteria. Annals of the ATS. 2019 Oct; 16(10): 1280-1285.
17. Wenger DS, Triplette M, Crothers K, Cheng GS, Hill JA, Milano F, Shahrir S, Schoch G, Vande Vusse LK. Incidence, Risk Factors and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 Feb; 26(2): 413-420.
18. Attia EF, Bhatraju PK, Triplette M, Kosamo S, Maleche-Obimbo E, West TE, Richardson B, Zifodya JS, Eskander S, Njiru CD, Warui D, Kicska GA, Chung MH, Crothers K, Liles WC, Graham SM. Endothelial activation, innate immune activation, and inflammation are associated with post-bronchodilator airflow limitation and obstruction among adolescents living with HIV. JAIDS. 2020 Mar 1; 83(3): 267-277.
19. Monu J, Triplette M, Wood D, Wolff E, Lavalle D, Flum D, Farjah F. Evaluating knowledge, attitudes and beliefs about lung cancer screening using crowdsourcing. Chest. 2020 Jul; 158(1): 386-392.
20. D’Arcy ME, Pfeiffer RM, Rivera DR, Hess G, Cahoon E, Aaron S, Brownell I, Cowen E, Israni A, Triplette M, Yanik E, Engels EA. Voriconazole and the risk of non-melanoma skin cancer among lung transplant recipients in the United States. Submitted to JAMA Dermatology, 2020 Jul 1; 156(7): 772-9.
21. Melzer AC, Golden SE, Ono SS, Datta S, Triplette M, Slatore CG. “We just never have enough time”: Clinician views of lung cancer screening processes and implementation. Annals of the ATS. 2020 Jun 4. Epub.
*22. Triplette M, Thayer JH, Kross EK, Cole AM, Wenger D, Farjah F, Nair VS, Crothers K. The impact of smoking and screen results on adherence to follow-up in an academic multisite lung cancer screening program. Annals of the ATS. 2021 Mar; 18(3): 545-547.
23. Wenger DS, Triplette M, Shahrir S, Akgun KM, Wongtrakool C, Brown ST, Kim JW, Soh Hoo GW, Rodriguez-Baarradas MC, Huang L, Feemster LC, Zifodya J, Crothers K. Associations of marijuana with markers of chronic lung disease in people living with HIV. HIV Med. 2021 Feb; 22(2):92-101.
24. Rivera MP, Katki HA, Tanner NT, Triplette M, Sakoda LC, Wiener RS, Cardarelli R, Carter-Harris L, Crothers K, Fathi JT, Ford ME, Smith R, Winn RA, Wisnivesky JP, Henderson LM, Aldrich MC. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2020 Oct 1; e95-e112.
25. Shen J, Crothers K, Kross EK, Petersen K, Melzer AC, Triplette M. Provision of smoking cessation resources in the context of in-person shared decision making for lung cancer screening. Chest. 2021 Aug; 160(2):765-775.
26. Carmona H, Allison S, Triplette M, Adamson R. Transthoracic Needle biopsy Am J Respir Crit Care Med. Jul 1; 204(1): P1-P2. [review]
27. Zifodya JS, Triplette M, Shahrir S, Attia EF, Akgun KM, Soo Hoo GW, Rodriguez-Barradas MC, Wongtrakool C, Tate JP, Huang L, Crothers K. Diagnosis and Management of COPD in HIV-infected individuals: Opportunities for Improvement. Medicine. August 2021. Epub ahead of print.
28. Triplette M, Wenger DS, Shahrir S, Kross EK, Kava C, Phipps A, Hawes SE, Cole A, Snidarich M, Crothers K. Patient understanding of lung cancer screening follow-up recommendations and the association with adherence. Annals of ATS. Accepted October 2021. Epub ahead of print.
29. Cancer Center Cessation Diversity, Equity and Inclusion Working Group (including Triplette M). Integrating diversity, equity and inclusion approaches into treatment of commercial tobacco use for optimal cancer care delivery. J Natl Compr canc Netw. 2021 Nov; 19(Supp_1): S4-S7.
b) Book chapters
1. Triplette M, Cheng, CS. “Mediastinal Tumors and Cysts.” Murray and Nadel’s Textbook of Respiratory Medicine, 7th edition. 2021.
c) Published books
None.
d) Other publications
1. Jonas D, Van Scoyoc E, Gerrald K, Wines R, Amick H, Triplette M, Runge T. Drug Class Review: Newer Diabetes Medications, TZDs and Combinations: Final Original Report. Portland (OR): Oregon Health & Sciences University; 2011 Feb. [review]
2. Triplette M, Houghton M. Immunotherapy in Lung Cancer: an interview with Dr. Triplette and Dr. Houghton. American Thoracic Society. Podcast available at: https://www.thoracic.org/about/ats-podcasts/immunotherapy-in-lung-cancer-an-interview-with-dr-triplette-and-dr-houghton.php.
3. Triplette M, Farjah F. A thoracic surgeons perspective on surgical resection of early stage lung cancer. Podcast available at: https://www.thoracic.org/about/ats-podcasts/a-thoracic-surgeons-perspective-on-surgical-resection-of-early-stage-non-small-cell-lung-cancer.php.